64 related articles for article (PubMed ID: 25455004)
1. Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma.
Szmit S; Jurczak W; Zaucha JM; Drozd-Sokołowska J; Spychałowicz W; Joks M; Długosz-Danecka M; Torbicki A
J Am Soc Hypertens; 2014 Nov; 8(11):791-9. PubMed ID: 25455004
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure.
Buege MJ; Drill E; Horwitz SM; LeVoir A; Pak T; Peterson TJ; Dao PH; Matasar MJ
Eur J Haematol; 2023 Jul; 111(1):96-102. PubMed ID: 36971022
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805.
Bottinor WJ; Flamand Y; Haas NB; ONeill AM; DiPaola RS; Subramanian P; Cella D; Hundley WG; Wagner LI; Salsman JM; Ky B
J Natl Compr Canc Netw; 2023 Jul; 21(7):725-731.e1. PubMed ID: 37433436
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac Dysfunction and Arterial Hypertension as Manifestations of Cardiovasculotoxicity of iVEGF-Containing Chemotherapy. Clinical Case].
Kirichenko YY; Kulagina TY; Zhigulina OA; Ilgisonis IS; Belenkov YN
Kardiologiia; 2024 May; 64(5):33-38. PubMed ID: 38841787
[TBL] [Abstract][Full Text] [Related]
5. The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review.
Conway A; McCarthy AL; Lawrence P; Clark RA
BMC Cancer; 2015 May; 15():366. PubMed ID: 25948399
[TBL] [Abstract][Full Text] [Related]
6. The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity.
Akolkar G; Bhullar N; Bews H; Shaikh B; Premecz S; Bordun KA; Cheung DY; Goyal V; Sharma AK; Garber P; Singal PK; Jassal DS
Cardiovasc Ultrasound; 2015 Apr; 13():18. PubMed ID: 25889218
[TBL] [Abstract][Full Text] [Related]
7. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.
Krischer JP; Epstein S; Cuthbertson DD; Goorin AM; Epstein ML; Lipshultz SE
J Clin Oncol; 1997 Apr; 15(4):1544-52. PubMed ID: 9193351
[TBL] [Abstract][Full Text] [Related]
8. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
[TBL] [Abstract][Full Text] [Related]
9. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM;
Eur Heart J; 2016 Sep; 37(36):2768-2801. PubMed ID: 27567406
[No Abstract] [Full Text] [Related]
10. Effect of hypertension on the optimal anthracycline cumulative dose for developing left ventricular dysfunction in patients with malignant lymphoma.
Tanaka Y; Tanaka H; Hatazawa K; Yamashita K; Sumimoto K; Shono A; Suzuki M; Yokota S; Suto M; Mukai J; Takada H; Matsumoto K; Minami H; Hirata KI
Int J Cardiovasc Imaging; 2022 May; 38(5):931-939. PubMed ID: 38819729
[TBL] [Abstract][Full Text] [Related]
11. Role of HDL cholesterol in anthracycline-induced subclinical cardiotoxicity: a prospective observational study in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Ou W; Jiang T; Zhang N; Lu K; Weng Y; Zhou X; Wang D; Dong Q; Tang X
BMJ Open; 2024 Feb; 14(2):e074541. PubMed ID: 38341200
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of patients with newly diagnosed hematological malignancies referred for echocardiography.
Kępski J; Szmit S; Lech-Marańda E
Front Oncol; 2024; 14():1283831. PubMed ID: 38327743
[TBL] [Abstract][Full Text] [Related]
13. Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management.
Askarinejad A; Alizadehasl A; Jolfayi AG; Adimi S
Cardiooncology; 2023 Dec; 9(1):46. PubMed ID: 38087384
[TBL] [Abstract][Full Text] [Related]
14. Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea.
Hwang HJ; Lee TG
PLoS One; 2023; 18(11):e0294649. PubMed ID: 37983233
[TBL] [Abstract][Full Text] [Related]
15. Differential Cardiovascular Outcomes of Each Antihypertensive Drug Class in Patients With Hypertension and Breast Cancer Undergoing Doxorubicin-Containing Chemotherapy.
Hwang HJ; Han SA
J Breast Cancer; 2023 Oct; 26(5):492-503. PubMed ID: 37704380
[TBL] [Abstract][Full Text] [Related]
16. Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation.
Butel-Simoes LE; Haw TJ; Williams T; Sritharan S; Gadre P; Herrmann SM; Herrmann J; Ngo DTM; Sverdlov AL
Hypertension; 2023 Apr; 80(4):685-710. PubMed ID: 36756872
[TBL] [Abstract][Full Text] [Related]
17. Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies.
Tini G; Tocci G; Battistoni A; Sarocchi M; Pietrantoni C; Russo D; Musumeci B; Savoia C; Volpe M; Spallarossa P
Curr Heart Fail Rep; 2023 Feb; 20(1):56-62. PubMed ID: 36696001
[TBL] [Abstract][Full Text] [Related]
18. Baseline blood pressure and development of cardiotoxicity in patients treated with anthracyclines: A systematic review.
Philip LJ; Findlay SG; Gill JH
Int J Cardiol Cardiovasc Risk Prev; 2022 Dec; 15():200153. PubMed ID: 36573186
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay.
Schirone L; D'Ambrosio L; Forte M; Genovese R; Schiavon S; Spinosa G; Iacovone G; Valenti V; Frati G; Sciarretta S
Cells; 2022 Jun; 11(13):. PubMed ID: 35805084
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
